Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAN 2021 | INTREPID trial: device features and study design

Jerrold Vitek, MD, PhD University of Minnesota, Minneapolis, MN, comments on the long-term evaluation of deep brain stimulation (DBS) for Parkinson’s disease (PD) using a multiple independent current control (MICC) device. The unique feature of this type of device is that each contact in the brain has a separate current source. Therefore, doctors can have better control over the current being delivered to each of the contacts in the brain. Dr Vitek explains the study setup and the planned analysis. This interview took place during the American Academy of Neurology (AAN) 2021 Annual Meeting.

Disclosures

Dr. Vitek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific, Abbott, and Surgical Information Sciences. Dr. Vitek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Vitek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Surgical Information Sciences. Dr. Vitek has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Vitek has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Vitek has received research support from NINDS.